Japan approves Genmab’s EPKINLY for R/R follicular lymphoma treatment
Genmab (GMAB) announced that the Japan Ministry of Health, Labour and Welfare has approved EPKINLY or epcoritamab, for the treatment of ...
MarketWatch20h
Phillips 66
Western Midstream Partners L.P.-0.62% $15.74B ...